These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 10375998

  • 21. Therapeutic potential of thromboxane inhibitors in asthma.
    Dogné JM, de Leval X, Benoit P, Rolin S, Pirotte B, Masereel B.
    Expert Opin Investig Drugs; 2002 Feb; 11(2):275-81. PubMed ID: 11829716
    [Abstract] [Full Text] [Related]

  • 22. Population analysis of the pharmacokinetics and pharmacodynamics of seratrodast in patients with mild to moderate asthma.
    Samara E, Cao G, Locke C, Granneman GR, Dean R, Killian A.
    Clin Pharmacol Ther; 1997 Oct; 62(4):426-35. PubMed ID: 9357394
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Blocking of thromboxane A₂ receptor attenuates airway mucus hyperproduction induced by cigarette smoke.
    An J, Li JQ, Wang T, Li XO, Guo LL, Wan C, Liao ZL, Dong JJ, Xu D, Wen FQ.
    Eur J Pharmacol; 2013 Mar 05; 703(1-3):11-7. PubMed ID: 23399768
    [Abstract] [Full Text] [Related]

  • 26. Identification of cytochromes P450 involved in the human liver microsomal metabolism of the thromboxane A2 inhibitor seratrodast (ABT-001).
    Kumar GN, Dubberke E, Rodrigues AD, Roberts E, Dennisen JF.
    Drug Metab Dispos; 1997 Jan 05; 25(1):110-5. PubMed ID: 9010637
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma.
    Hoshino M, Sim J, Shimizu K, Nakayama H, Koya A.
    J Allergy Clin Immunol; 1999 Jun 05; 103(6):1054-61. PubMed ID: 10359886
    [Abstract] [Full Text] [Related]

  • 33. In vitro effect of DP-1904, a novel anti-asthma agent, against antigen-induced constriction and TXB2 release from the isolated guinea-pig lung parenchymal tissue.
    Takami M, Tsukada W.
    Pharmacol Res; 1998 Aug 05; 38(2):141-7. PubMed ID: 9721602
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Synergism between cysteinyl leukotrienes and thromboxane A2 to induce allergic late phase nasal blockage in guinea pigs.
    Nakanishi Y, Nabe T, Mizutani N, Takenaka H, Kohno S.
    Prostaglandins Other Lipid Mediat; 2004 Oct 05; 74(1-4):125-37. PubMed ID: 15560121
    [Abstract] [Full Text] [Related]

  • 36. [The effect of a specific thromboxane A2 antagonist, AA-2414 on airway hyperresponsiveness induced by ozone exposure in dogs].
    Imai T, Adachi M, Idaira K, Suganuma T, Takahashi T, Yamaguchi H, Saito C, Maeda M, Tsuji A.
    Arerugi; 1991 Jan 05; 40(1):28-36. PubMed ID: 1827576
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Eicosanoid receptors as therapeutic targets for asthma.
    Powell WS.
    Clin Sci (Lond); 2021 Aug 27; 135(16):1945-1980. PubMed ID: 34401905
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.